Ani Pharmaceuticals reported $24.26M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aerie Pharmaceuticals AERI:US $ 79.96M 42.74M
Ani Pharmaceuticals ANIP:US $ 24.26M 0.81M
Aurora Cannabis Inc ACB:CN 421.46M 48.78M
Biodelivery Sciences International BDSI:US 119.85M 3.42M
Canopy Growth Corp WEED:CN C$ 192.56M 525.51M
Depomed DEPO:US $ 54.43M 6.6M
Eli Lilly And LLY:US $ 3220M 217.6M
Emergent Biosolutions EBS:US $ 447.5M 100.3M
Endo International Ordinary Shares ENDP:US $ 1545.17M 117.4M
Flexion Therapeutics FLXN:US $ 107.63M 8.92M
Heron Therapeutics HRTX:US $ 191.17M 131.43M
Hikma Pharmaceutical HIK:LN 2M 321M
Knight Therapeutics Inc GUD:CN C$ 2.3M 4.59M
Lannett LCI:US $ 93.29M 12M
Nektar Therapeutics NKTR:US $ 152.34M 2.18M
Novartis NVS:US $ 5117M 1316M
Omeros OMER:US $ 12.7M 3.67M
Perrigo Ordinary Shares PRGO:US $ 317.5M 153.4M
Teva Pharmaceutical TEVA:IT 2.44B 693M
Teva Pharmaceutical Industries TEVA:US $ 2436M 693M